| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |